Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GE Junction Cancer”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03448835
What this trial is testing

Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

Who this might be right for
Stomach CancerGastro Esophageal Junction Cancer
The Netherlands Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT00256269
What this trial is testing

Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma

Who this might be right for
Esophageal CancerGastroesophageal Cancer
University of California, Irvine 4
Testing effectiveness (Phase 2)Study completedNCT00165191
What this trial is testing

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Who this might be right for
Adenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus
Dana-Farber Cancer Institute 32
Not applicableWithdrawnNCT05067842
What this trial is testing

Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma Esophagus
Medical College of Wisconsin
Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00952497
What this trial is testing

Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
ACT Biotech, Inc 48
Early research (Phase 1)Study completedNCT03279237
What this trial is testing

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Who this might be right for
GastroEsophageal Cancer
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT02317991
What this trial is testing

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Cancer
SCRI Development Innovations, LLC 65
Testing effectiveness (Phase 2)Ended earlyNCT00103103
What this trial is testing

Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Who this might be right for
Gastric Cancer
California Cancer Consortium
Testing effectiveness (Phase 2)Ended earlyNCT00561197
What this trial is testing

An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Esophageal or GE Junction Cancer
Ascenta Therapeutics 13
Testing effectiveness (Phase 2)Looking for participantsNCT07353684
What this trial is testing

Adebrelimab, Apatinib & SOX for Conversion Therapy in Advanced Gastric/GEJ Cancer

Who this might be right for
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital 49
Not applicableLooking for participantsNCT01048281
What this trial is testing

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Who this might be right for
Stomach CancerGastro-Esophageal(GE) Junction CancerGastric (Stomach) Cancer+2 more
Stanford University 100
Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing

HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.
Very early researchStudy completedNCT00215514
What this trial is testing

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach CancerGastric CancerGastro-esophageal Junction Cancer
Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00086996
What this trial is testing

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 98
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00526669
What this trial is testing

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
GlaxoSmithKline 68
Testing effectiveness (Phase 2)Ended earlyNCT01774851
What this trial is testing

MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Who this might be right for
HER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more
Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)UnknownNCT04119622
What this trial is testing

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric Cancer Stage IIGastric Cancer Stage III
Aiping Zhou 30
Testing effectiveness (Phase 2)Study completedNCT00319735
What this trial is testing

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Who this might be right for
Esophageal Cancer
Nasser Hanna, M.D. 41
Load More Results